Alenson Carman bought PRME
February 23, 2026 · Form 4 insider transaction
Alenson Carman bought 140,000 shares of Prime Medicine, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
140,000
Price
$0.00
Total value
N/A
InsiderAlenson Carman
Role—
CompanyPrime Medicine, Inc. (PRME)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 23, 2026
Filing dateFebruary 24, 2026
Shares owned after140,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 23, 2026, subject to the Reporting Person's continued service on each such vesting date.